| Literature DB >> 22822379 |
Roberta Teta1, Gerardo Della Sala1, Barbara Renga2, Alfonso Mangoni1, Stefano Fiorucci2, Valeria Costantino1.
Abstract
Chalinulasterol (1) a new chlorinated sterol disulfate was isolated from the Caribbean sponge Chalinula molitba. Its structure was elucidated using mass spectrometry and NMR experiments. The possible role of chalinulasterol as modulator of the PXR nuclear receptor was investigated but, in spite of the close structural relationship with the PXR agonist solomonsterol A (2), it showed no activity. The structural requirements for the PXR nuclear receptor activity were discussed.Entities:
Keywords: Chalinula molitba; PXR modulator; chlorine-containing steroid; sterol sulfate; structure elucidation
Mesh:
Substances:
Year: 2012 PMID: 22822379 PMCID: PMC3397446 DOI: 10.3390/md10061383
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 6.085
Figure 1Structures of chalinulasterol (1) and of solomonsterol A (2) and B (3).
Figure 2(a) Selected COSY and HMBC correlations of 1, represented as bold bonds and arrows, respectively. (b) Selected ROESY correlations detected for 1.
1H (700 MHz) and 13C (175 MHz) NMR data of chalinulasterol (1)in CD3OD.
| Pos. | δH [mult. a,
| δC [mult.] | Pos. | δH [mult. a,
| δC [mult.] | ||
|---|---|---|---|---|---|---|---|
| 1 | α/ax | 1.38 (dd, 14.6, 3.5) | 39.1 (CH2) | 13 | - | 43.8 (C) | |
| β/eq | 2.12 (dd, 14.6, 2.1) | 14 | 1.05 (m) | 57.8 (CH) | |||
| 2 | 4.72 (q, 2.7) | 76.5 (CH) | 15 | α | 1.59 (m) | 25.2 (CH2) | |
| 3 | 4.69 (q, 2.7) | 76.3 (CH) | β | 1.08 (m) | |||
| 4 | α/eq | 1.66 (dt, 14.6, 2.7) | 30.4 (CH2) | 16 | α | 1.86 (ddd, 14.6, 9.4, 3.9) | 29.3 (CH2) |
| β/ax | 1.79 (ddd, 14.6, 12.6, 2.7) | β | 1.28 a | ||||
| 5 | 1.62 (tt, 12.6, 2.7) | 40.3 (CH) | 17 | 1.12 (q, 9.7) | 57.5 (CH) | ||
| 6 | α/eq | 1.25 (br. d, 14.5) | 29.2 (CH2) | 18 | 0.69 (s) | 12.8 (CH3) | |
| β/ax | 1.29 (qd, 12.7, 3.5) | 19 | 1.01 (s) | 14.2 (CH3) | |||
| 7 | α/ax | 0.95 (qd, 12.6, 4.6) | 33.3 (CH2) | 20 | 1.44 (m) | 36.6 (CH) | |
| β/eq | 1.68 (dq, 13.0. 3.3) | 21 | 0.95 (d, 6.5) | 19.2 (CH3) | |||
| 8 | 1.41 (qd, 11.2, 3.5) | 36.5 (CH) | 22 | a | 1.56 (dddd, 13.4, 10.6, 5.6, 2.9) | 34.4 (CH2) | |
| 9 | 0.72 (ddd, 13.2, 10.5, 3.8) | 56.7 (CH) | b | 1.15 (dddd, 13.4, 10.6, 8.8, 4.3) | |||
| 10 | - | 36.4 (C) | 23 | a | 1.81 (ddtd, 13.9, 11.2, 7.1, 4.5) | 30.6 (CH2) | |
| 11 | α/eq | 1.53 (dq, 14.1, 3.5) | 22.1 (CH2) | b | 1.65 (ddq, 13.9, 10.9, 5.7) | ||
| β/ax | 1.33 (qd, 13.2, 3.7) | 24 | a | 3.53 (dt, 10.7, 6.5) | 46.4 (CH2) | ||
| 12 | α/ax | 1.14 (td, 12.6, 3.8) | 41.4 (CH2) | b | 3.51 (ddd, 10.7, 7.1, 6.4) | ||
| β/eq | 1.99 (dt, 12.2, 3.5) |
a Multiplicity and coupling constants of overlapping signals were determined using sections of the zTOCSY spectrum [11]; dt = doublet of triplets, td = triplet of doublets, dq = doublet of quartets, etc.
Figure 3(A,B) Luciferase reporter assay. HepG2 cells, a hepatocarcinoma cell line, were transiently transfected with pSG5-PXR, pSG5-RXR, pCMV-βgalactosidase and p(CYP3A4)-TK-Luc vectors and then stimulated with (A) 10 µM rifaximin, solomonsterol A (2) or chalinulasterol (1) for 18 h, or (B) 10 µM rifaximin alone or in combination with 50 µM of compounds 1. Relative Luciferase Units were normalized with β-galactosidase Units (RLU/βgal). NT, not treated. *P<0.05 versus NT cells. Data are mean ± SE of three experiments. (C) Real-Time PCR of Cyp3A4. HepG2 cells were stimulated with 10 µM rifaximin, 2 or 1 for 18 h. Total RNA was extracted and the relative mRNA levels of PXR target gene Cyp3A4, was measured. Values were normalized relative to GAPDH mRNA and are expressed relative to those of untreated mice, which are arbitrarily set to 1. Analysis was carried out in triplicate and the experiment was repeated twice. NT, not treated. *P<0.05 versus NT cells.